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Background: Transportin-SR2 (TRN-SR2/TNPO3) is a human karyopherin encoded by the 
TNPO3 gene. We identified TRN-SR2 as a binding partner of HIV-1 integrase (IN) and 
validated TRN-SR2 as an important cellular cofactor for the nuclear import of HIV-1. 
However, the question still remained whether the direct interaction between TRN-SR2 and 
IN mediates the nuclear import of HIV.  
Methods: By peptide screening we analyzed the interaction between TRN-SR2 and IN in 
molecular detail. Protein-protein interactions were verified by co-IP and AlphaScreen. We 
engineered site specific mutants in the C-terminal domain of HIV-1 IN that display reduced 
interaction with TRN-SR2 and studied their role in HIV replication using Q-PCR and 
fluorescence microscopy. 
Results: Using the AlphaScreen protein-protein interaction assay we have been able to 
pinpoint the interacting hot spots in IN to R262/R263/K264 and K266/R269 in the IN C-
terminal domain. We also identified a secondary interaction surface involving residues 
F185/K186/R187 and K188 in the catalytic core domain. Next, we introduced mutations at 
these positions in the C-terminal domain in the virus to corroborate the biological relevance 
of the interaction. Several mutations in the C-terminal domain of HIV IN inhibited the 
IN/TRN-SR2 interaction and rendered the virus replication-deficient. Some mutants affected 
reverse transcription (RT) compromising analysis of HIV nuclear import. All mutants also 
affected integrase activity. Still, one mutant, INR263A/K264A, retained full RT activity but 
displayed a specific block at the level of nuclear import as measured by Q-PCR and 
fluorescence microscopy. Although this mutant was defective for integration, no increase in 
2-LTR circles was detected. Moreover, HIV encoding INR263A/K264A showed reduced nuclear 
import when assayed with an eGFP-IN labeled HIV. 
Conclusion: The INR263A/K264A mutation in the C-terminal domain of HIV-1 integrase 
reduces the interaction with TRN-SR2 and specifically blocks HIV replication at the stage of 
nuclear import, corroborating the importance of this direct protein-protein interaction in HIV 
nuclear import. 
 
 
